I agree that the false positives (I wouldn’t call these mistakes, and certainly not screw ups) might be about as common as with other companies. After all, they

I agree that the false positives (I wouldn’t call these mistakes, and certainly not screw ups) might be about as common as with other companies. After all, they often more or less did the same tests (but IIRC, ¿sometimes? with samples that were too small to work well) I also think it would be much harder to prove intent to hurt than intent to defraud investors, making it easier to prosecute for fraud.